Use the translation strategy "From patients to the lab, back to patients"
Develop the concept of “Singularity in Cancer Medicine”
Focus on identifying individualized Biologic / “Molecular profiles at n variables”, applied to cancer screening/early detection and the individual prediction of treatment efficacy/resistance and biologic adaptation/evolution of cancer.
Use Femto/Attosecond infrared (IR) laser technology (Quantum Optics) to access individual molecular fingerprints with unprecedented selectivity and sensitivity via broadband mid-infrared (MIR) vibrational spectroscopy and for label-free biological microscopy with broadband near-infrared (NIR) light in plasma (Liquid biopsies -Blood).
Use of Next Generation Sequencing (DNA Methylation) in liquid biopsies, applying the concept of Singularity
Use Artificial Intelligence batteries of algorithmic tests to address, on binary mode, unmet needs in cancer medicine and biology.
ICR Group is developing a cancer program, based upon dynamic blood molecular mapping, to create a “Molecular Cancer Operating System” (“Cancer Translational Platform”) through the fusion/interaction of Quantum Physics, Artificial Intelligence, and cancer medicine and biology. This approach introduces the concept of Singularity, breaking from the concept of causality and precluding the Quantum Precision medicine of the XXIst century.
